本文選題：腫瘤 + 臨床試驗(yàn)　； 參考：《中國(guó)新藥與臨床雜志》2015年12期

【摘要】：通過(guò)分析腫瘤臨床試驗(yàn)知情同意過(guò)程、隨訪安排、訪視接待及生存隨訪過(guò)程中受試者管理的問(wèn)題和方法,探討研究者、研究護(hù)士、臨床研究協(xié)調(diào)員、受試者本人及試驗(yàn)設(shè)計(jì)本身對(duì)受試者管理的影響和作用,為后續(xù)腫瘤臨床試驗(yàn)開(kāi)展過(guò)程中受試者的管理提供參考。
[Abstract]:By analyzing the process of informed consent, arrangement of follow-up, interview reception and survival follow-up, the problems and methods of subject management in tumor clinical trial were analyzed, and the researchers, research nurses and clinical research coordinators were discussed. The effects of the subjects themselves and the design itself on the management of the subjects provide a reference for the management of the subjects in the course of the follow-up clinical trials of cancer.
【作者單位】： 北京大學(xué)腫瘤醫(yī)院暨北京市腫瘤防治研究所國(guó)家藥物臨床試驗(yàn)機(jī)構(gòu)惡性腫瘤發(fā)病機(jī)制及轉(zhuǎn)化研究教育部重點(diǎn)實(shí)驗(yàn)室;
【分類號(hào)】：R95
，

本文編號(hào)：1881004